(2S,2'S,2''S)-N,N',N''-((4S,4'S,4''S,7S,7'S,7''S)-20,20',20''-((2S,5R,8S,11R,14S,17R)-5,11,17-trimethyl-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexaazacyclooctadecane-2,8,14-triyl)tris(4,7-bis(4-hydroxybenzyl)-2,5,8,15-tetraoxo-3'',6'',9'',16''-tetraazaicosane-20,1-diyl))tris(2,6-diaminohexanamide)

ID: ALA1241017

Chembl Id: CHEMBL1241017

PubChem CID: 16159336

Max Phase: Preclinical

Molecular Formula: C123H183N27O27

Molecular Weight: 2471.98

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  C[C@H]1NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CCCCNC(=O)CCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](N)CCCCN)NC1=O

Standard InChI:  InChI=1S/C123H183N27O27/c1-76-109(163)145-95(29-14-23-62-131-104(158)32-8-5-20-65-134-116(170)98(68-80-36-48-86(152)49-37-80)149-122(176)101(71-83-42-54-89(155)55-43-83)143-107(161)74-137-113(167)92(128)26-11-17-59-125)119(173)140-78(3)111(165)147-96(30-15-24-63-132-105(159)33-9-6-21-66-135-117(171)99(69-81-38-50-87(153)51-39-81)150-123(177)102(72-84-44-56-90(156)57-45-84)144-108(162)75-138-114(168)93(129)27-12-18-60-126)120(174)141-77(2)110(164)146-94(118(172)139-76)28-13-22-61-130-103(157)31-7-4-19-64-133-115(169)97(67-79-34-46-85(151)47-35-79)148-121(175)100(70-82-40-52-88(154)53-41-82)142-106(160)73-136-112(166)91(127)25-10-16-58-124/h34-57,76-78,91-102,151-156H,4-33,58-75,124-129H2,1-3H3,(H,130,157)(H,131,158)(H,132,159)(H,133,169)(H,134,170)(H,135,171)(H,136,166)(H,137,167)(H,138,168)(H,139,172)(H,140,173)(H,141,174)(H,142,160)(H,143,161)(H,144,162)(H,145,163)(H,146,164)(H,147,165)(H,148,175)(H,149,176)(H,150,177)/t76-,77-,78-,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+/m1/s1

Standard InChI Key:  IJZLPDMLJGSJCC-GTBINUOFSA-N

Alternative Forms

1. Parent:

   

   ALA1241017

   (2S)-2,6-diamino-N-[2-[[(2S)-1-[[(2S)-1-[[6-[4-[(2S,5R,8S,11R,14S,17R)-8,14-bis[4-[6-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2,6-diaminohexanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoylamino]butyl]-5,11,17-t

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 2471.98

Molecular Weight (Monoisotopic): 2470.3777

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Fournel S, Wieckowski S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G..  (2005)  C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L.,  1  (7): [PMID:16370373] [10.1038/nchembio746]

Source

Source(1):

• Scientific Literature